IRIS
FRIES, Walter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.703
EU - Europa 5.040
AS - Asia 4.072
SA - Sud America 1.728
AF - Africa 108
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 17.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.579
SG - Singapore 1.831
BR - Brasile 1.524
SE - Svezia 1.212
IE - Irlanda 1.179
CN - Cina 1.059
HK - Hong Kong 611
DE - Germania 493
IT - Italia 409
UA - Ucraina 382
FR - Francia 335
GB - Regno Unito 283
FI - Finlandia 230
RU - Federazione Russa 222
VN - Vietnam 200
PL - Polonia 108
AR - Argentina 71
IN - India 63
BD - Bangladesh 55
CA - Canada 49
MX - Messico 46
AT - Austria 38
ZA - Sudafrica 36
TR - Turchia 35
EC - Ecuador 34
NL - Olanda 34
JP - Giappone 26
MA - Marocco 26
BE - Belgio 25
CO - Colombia 25
IQ - Iraq 24
ID - Indonesia 21
PY - Paraguay 20
UZ - Uzbekistan 20
ES - Italia 19
VE - Venezuela 17
AZ - Azerbaigian 15
CL - Cile 13
KZ - Kazakistan 13
PK - Pakistan 13
PE - Perù 12
JO - Giordania 11
KE - Kenya 11
AU - Australia 10
NP - Nepal 10
TN - Tunisia 9
AL - Albania 8
IL - Israele 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
LT - Lituania 7
SN - Senegal 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
RS - Serbia 6
GA - Gabon 5
GE - Georgia 5
KR - Corea 5
LV - Lettonia 5
NI - Nicaragua 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
OM - Oman 5
RO - Romania 5
CR - Costa Rica 4
IR - Iran 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
DZ - Algeria 3
EE - Estonia 3
EU - Europa 3
GR - Grecia 3
GT - Guatemala 3
LK - Sri Lanka 3
MY - Malesia 3
PA - Panama 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
AM - Armenia 2
AO - Angola 2
BW - Botswana 2
CI - Costa d'Avorio 2
EG - Egitto 2
LU - Lussemburgo 2
PS - Palestinian Territory 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
DK - Danimarca 1
GH - Ghana 1
GY - Guiana 1
Totale 17.662
Salva come PNG Salva come JPEG
Città #
Dublin 1.175
Chandler 953
Singapore 903
Dallas 783
Jacksonville 763
Ashburn 638
Hong Kong 611
Nyköping 509
Beijing 433
Princeton 220
Dearborn 191
Cambridge 184
Des Moines 173
Los Angeles 173
Medford 143
Messina 136
São Paulo 124
Buffalo 122
Lancaster 117
Boardman 113
The Dalles 107
Munich 104
Ann Arbor 94
Warsaw 88
Moscow 84
Ho Chi Minh City 81
Woodbridge 69
Redondo Beach 60
Jinan 58
Rio de Janeiro 53
Wilmington 52
Bremen 50
Shenyang 49
Tianjin 47
Belo Horizonte 43
San Mateo 42
Hanoi 38
Seattle 38
New York 35
Turku 35
Nuremberg 32
Zhengzhou 27
Hebei 26
Brasília 25
Houston 25
Brooklyn 24
Brussels 24
Ningbo 24
Tokyo 24
Nanjing 23
Curitiba 22
Vienna 22
Frankfurt am Main 21
London 21
Campinas 20
Catania 19
Haikou 19
Stockholm 19
Hangzhou 18
Helsinki 18
Changsha 17
Denver 17
Porto Alegre 17
San Francisco 17
Tashkent 17
Washington 17
Boston 16
Dhaka 16
Santa Clara 16
Baku 15
Düsseldorf 15
Amsterdam 14
Hyderabad 14
Jiaxing 14
Poplar 14
Taizhou 14
Guangzhou 13
Johannesburg 13
Milan 13
Nanchang 13
Chennai 12
Fortaleza 12
Osasco 12
Quito 12
Ribeirão Preto 12
Rome 12
Atlanta 11
Bogotá 11
Chicago 11
Council Bluffs 11
Goiânia 11
Guarulhos 11
Guayaquil 11
Lauterbourg 11
Sorocaba 11
São Bernardo do Campo 11
Uberlândia 11
Betim 10
Cape Town 10
Joinville 10
Totale 10.669
Salva come PNG Salva come JPEG
Nome #
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 163
Combined approach with biologics and surgery for entero-cutaneous fistulas in Crohn’s disease 136
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature 129
Optical coherence tomography evaluation of ulcerative colitis: The patterns and the comparison with histology 129
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat 129
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. 129
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 127
A three year pilo study with 1,25 dihydroxyvitamin D, calcium and calcitonin for severe osteodystrophy in primary biliary cirrhosis 124
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 123
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 120
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 117
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 116
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 116
Alexithymia and inflammatory bowel disease: A systematic review 115
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 113
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 112
Metacognitions and basic emotions in patients with irritable bowel syndrome and inflammatory bowel disease 112
Guide to magnetic resonance in Crohn's disease: from common findings to the more rare complicances. 111
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 110
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy. 109
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 106
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. 106
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 105
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study 105
Hepatocyte tight-junctional permeability is increased in rat experimental colitis. 104
Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort. 104
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 104
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 104
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 103
Age is a Risk Factor for Severe Infections and Mortality in Patients given Anti-Tumor Necrosis Factor Therapy for Inflammatory bowel disease. 103
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 103
IBD-associated bone loss: is inflammation the explanation? 102
OCT Performance in the Diagnosis of Ulcerative Colitis 102
Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey. 102
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 101
Vitamin D and inflammatory bowel disease 100
A “real life” experience of infliximab use for Crohn’s disease in southern Italy 99
Association between previously identified disease loci at chr12q15 and chr1p36 and UC in Italian population 99
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study 99
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 98
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 98
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 97
The aged gut in inflammatory bowel diseases. 97
Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series 96
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 96
Gastric permeability of sucrose is increased in portal hypertensive gastropathy. 95
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. 95
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 95
DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography? 94
Osteopenia following total gastrectomy in the rat - state of mineral metabolism and bone histomorphometry 94
Gastric fundectomy in the rat - effects on mineral bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis 93
Analisi molecolare dei geni TLR4 e CARD15/NOD2 in pazienti affetti da malattie infiammatorie croniche intestinali: dati preliminari in una popolazione del sud Italia 93
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 93
Microradiographic anatomy of the explanted rat colon 92
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report 92
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. 92
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice. 92
Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis 91
Gastric permeability to sucrose is increased in portal hypertensive gastropathy 91
Thiopurine treatment in inflammatory bowel disease: response predictors, safety and withdrawal in follow-up. 91
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 91
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in southern Italy 91
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis 91
Clinical practice in the management of ulcerative colitis - an Italian survey 90
Association Between Previously Identified Disease Loci At Chr12q15 and Chr1p36 and UC in Italian Population. 88
Therapy-related adverse events in Crohn’s disease (CD) – a comparison between thiopurines, infliximab and combined therapy. 88
Bone metabolism in orthotopic liver transplantation: a prospective study 87
GASTROINTESTINAL PERMEABILITY IS INCRISED IN SCLERODERMA PATIENTS 87
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 87
Experimental colitis increases small intestine permeability in the rat 87
Anti-TNF therapy in elderly people in IBD; an Italian multicentre survey 87
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice 87
Effect of experimental colitis on bone metabolism in the rat 86
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease 86
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 86
Mucosal Immunology and Probiotics. 86
Sealing The Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions. 86
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 86
The Optical Coherence Tomography in Inflammatory Bowel Disease (IBD): Prospective Evaluation of 35 Patients 85
Hongos productores de biopelículas como causa emergente de infecciones por vía hemática en la enfermedad inflamatoria intestinal 85
Inflammatory Bowel Disease in the Elderly – Knowledge Gaps and Potential Directions in Research 85
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 85
Effects of anti COX-2, nabumetone and aspirin on gastric and intestinal permeability on healthy volunteers 84
Predicting response to thiopurines – a single centre experience. 84
Contenuti metacognitivi e alessitimia in un gruppo di soggetti con disturbi gastrointestinali. Uno studio esplorativo 84
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 83
Treatment of life threatening type I refractory celiac disease with long term infliximab 82
Extra-gastric effects of highly selective vagotomy. Bone and mineral metabolism in the rat. 82
Acute onset of Lupus associated Pancreatitis Mimicking Pancreatic Cancer 82
Adalimumab In Active Ulcerative Colitis: A “Real-Life” Observational Study on behalf of the Italian Group for the study of Inflammatory Bowel Disease. 82
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial 82
Bone density and calcium metabolism in patients with long standing, quiescent Crohn's disease 80
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 79
Le porfirie 78
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. 78
Cytomegalovirus pneumonia in patients with inflammatory bowel disease: a systematic review. 78
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 77
Hepatitis virus infections (HBV, HCV) in inflammatory bowel disease: A multicenter GISC study. 77
TNF-alpha inhibition prevents early tight junction rearrangement and apoptosis of ileal enterocytes in experimental colitis. 76
Thiopurines in the treatment of inflammatory bowel diseases – a single centre experience. 76
Totale 9.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021711 0 0 0 0 0 166 57 116 23 156 107 86
2021/20221.422 8 191 30 42 45 15 62 46 15 337 196 435
2022/20233.433 304 280 156 303 288 323 39 178 1.418 17 91 36
2023/2024798 70 117 88 133 89 103 21 30 2 69 8 68
2024/20254.406 64 56 129 233 255 199 147 886 1.123 228 341 745
2025/20264.033 470 775 871 756 984 177 0 0 0 0 0 0
Totale 18.115